For investors looking for growth, biotech stocks are a great place to start one’s search. This is a sector that’s seen its valuation multiples decline in many cases to a greater extent than the overall market. Thus, while many biotech stocks exhibit strong growth trajectories, these companies often trade at bargain prices. Much of that has…

Source: JHVEPhoto / Shutterstock.com Ardelyx (NASDAQ:ARDX) stock is taking off on Thursday after an advisory committee to the U.S. Food and Drug Administration (FDA) voted in favor of its kidney disease drug. This saw the FDA’s Cardiovascular and Renal Drugs Advisory Committee vote that the benefits of XPHOZAH outweigh the risks. That vote was nine…

Copyright © 2021 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201. Home / Today’s Market / Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving Today There’s more than just pumps moving penny stocks today By William White, InvestorPlace Writer Oct 13, 2021, 12:05 pm EDT October…

NeuroMetrix (NASDAQ:NURO) stock is surging higher on Tuesday after getting “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA). Source: Shutterstock The breakthrough designation is for NeuroMetrix’s Quell device designed to treat symptoms in adult patients suffering from fibromyalgia. This is due to the unmet need for managing pain from fibromyalgia without pharmacological…

Peloton (NASDAQ:PTON) stock is pushing higher today thanks to a deal with UnitedHealth Group (NYSE:UNH) that will have the two working together. Source: JHVEPhoto / Shutterstock.com UnitedHealth Group reveals in a press release that it’s opening up access to the Peloton app to eligible members. This will allow them access to 0n-demand videos and workout…

Shares of Ardelyx (NASDAQ:ARDX) are doing Tuesday morning what biotech stocks usually do in reaction to bad news. In this case, ARDX stock is off by more than 70% at the market open. Source: Shutterstock That bad news? It’s a July 13 letter from the Food and Drug Administration (FDA) regarding the company’s New Drug…